Journal of community hospital internal medicine perspectives

Review of Clinical Trials Testing Treatments for Long COVID

Long Covid Weekly Brief ↗PubMed ↗DOI ↗

Updated

Abstract

A systematic review was conducted to evaluate the efficacy and safety of interventions for long COVID.

  • Long COVID is associated with a variety of persistent symptoms following initial COVID-19 infection.
  • Efficacy and safety of interventions for long COVID remain unclear due to limited existing studies.
  • The review highlights the critical need for effective treatment options for patients suffering from long COVID.

Simplified

Related papers

Nov '22
Folic acid supplements and malaria risk and severity in people using antifolate malaria drugs in affected areas
cited by 30 papers
systematic review
Oct '20
Plasma or immune antibody treatments for people with COVID-19: an ongoing review
cited by 45 papers
systematic review
Aug '21
Treatments to relieve symptoms in patients with COVID-19 receiving palliative care
cited by 11 papers
systematic review
May '21
Convalescent plasma or high-antibody treatment for people with COVID-19: an ongoing review
cited by 57 papers
systematic review
Nov '24
Benefits, risks, and preferences of falls prevention methods for older adults living at home
top 5% journal
cited by 37 papers
systematic review
Sep '20
Behavioral treatments for unexplained medical symptoms in primary care: reviews and cost analysis
top 10% journal
cited by 43 papers
systematic review
Aug '24
Education and psychological support to help manage eczema
cited by 15 papers
systematic review
Oct '20
The Future Directions of Cochrane Neonatal Research
top 30% journal
cited by 19 papers
research support, non-u.s. gov't
Jul '20
Convalescent plasma or antibody treatment for people with COVID-19: an ongoing review
cited by 78 papers
systematic review

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the long covid brief

issue #53
Paxlovid didn't fix long COVID in a randomized trial. Here's what that means.
1 week ago7 studies
issue #52
Long COVID muscle changes look nothing like what happens after 60 days of bed rest
2 weeks ago5 studies
issue #51
Your gut bacteria during COVID infection may predict whether you develop long COVID
3 weeks ago7 studies
issue #50
A probiotic just beat placebo for long COVID fatigue in a randomized trial
4 weeks ago7 studies
issue #49
Dormant viruses wake up during COVID — and some are still active in long COVID patients
5 weeks ago7 studies
issue #48
A drug combo for post-COVID heart inflammation just ran a full trial. The primary endpoint didn't move.
6 weeks ago7 studies
issue #47
Women with long COVID face more severe neurological symptoms than men, new data shows
7 weeks ago7 studies
issue #46
Paxlovid didn't prevent long COVID in a randomized trial. Now what?
8 weeks ago7 studies
issue #45
A UK trial tested three repurposed drugs for long COVID fatigue. Here's what happened.
9 weeks ago7 studies
issue #44
A randomized trial tested cognitive rehab for long COVID brain fog — here's what happened
10 weeks ago7 studies
explore the archive
See more issues from the long covid brief